Safe Supply talks traction, rebrand, first sale

Executive Summary

• Safe Supply Streaming Co. Ltd. released a comprehensive corporate update highlighting a transition from portfolio assembly to initial operational activities, including pilot deployments and stakeholder engagement.
• The company announced plans for a strategic rebrand, including a corporate name change and corresponding ticker symbol change, subject to regulatory and exchange approvals, to better align with its evolution into a multivertical medical technology platform.
• Management reported the completion of its first commercial transaction under an exclusive Canadian distribution agreement with Nirlab SA, involving the sale of a drug analysis device to Far North Resources Inc., alongside active government engagement and demonstrations in Ottawa.

Key Details

• Strategic Rebrand: Plans to change corporate name and ticker symbol to reflect evolution into a multivertical medical technology platform spanning health, safety, and wellness; subject to regulatory and exchange approvals.
• First Commercial Transaction: Completed the sale of a Nirlab SA drug analysis device to Far North Resources Inc., marking the first transaction under Safe Supply's exclusive Canadian distribution agreement with Nirlab.
• Government Engagement: Conducted meetings in Ottawa with federal, provincial, municipal, and indigenous agencies, including live demonstrations of the Nirlab device to discuss public safety and evidence-based policy responses.
• Product Commercialization (Safety Strips): Preparing for commercialization of proprietary rapid testing products (fentanyl and drink-spiking detection strips) through wholly owned subsidiaries Safety Strips Tech Corp. and Drug Lab 118 Ltd.
• Distribution Strategy: Intends to commercialize Safety Strips in the US and Canada via government procurement channels, institutional partners, and direct-to-consumer (D2C) platforms, pending regulatory requirements and market readiness.
• GLP-1 Initiatives: Continuing to advance GLP-1-related health and wellness initiatives, focusing on delivery innovation, accessibility, and platform integration rather than commoditized approaches.
• Capital Strength: Recently completed an "upsized financing" to strengthen the balance sheet and enhance execution capabilities for near-term commercialization and portfolio expansion.
• Investment Criteria: Focus on evaluating technically advanced systems with strong scientific foundations, defensible intellectual property/exclusivity, and scalable commercialization potential.

Notable Quotes

• "The completion of our first Nirlab device sale marks an important operational milestone for Safe Supply. This transaction represents the initial execution under our exclusive Canadian distribution agreement with Nirlab." — Geoff Benic, Chief Executive Officer
• "Safe Supply is positioning itself at the intersection of innovation, public safety and wellness. These are areas of increasing importance for governments, institutions and communities alike." — Raf Souccar, Chairman of the Board